EM Karuna / shutterstock.com
Fake drugs cost EU pharmaceutical companies up to €10.2 billion ($11.4 billion) annually, a new report from the European Union Intellectual Property Office (EUIPO) has revealed.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Counterfeit drugs, IP, infringement, EUIPO, report, The Economic Cost of IPR Infringement in the Pharmaceutical Industry